Press Release - October 04, 2022 Personalis Forms Research Collaboration to Better Predict Immunotherapy Response for Gastroesophageal Cancer Read More
Press Release - August 30, 2022 Personalis to Present at the Morgan Stanley 20th Annual Global Healthcare Conference Read More More Press Releases
Press Release - August 17, 2022 Personalis Adds New MRD Patent Covering the Combination of Tumor-Informed and Database-Derived Content to Patent Infringement Complaint Against Foresight Diagnostics Read More More Press Releases
Press Release - August 16, 2022 Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Read More More Press Releases
Press Release - August 15, 2022 Personalis in Partnership with BC Cancer to Assess Clinical and Economic Benefits of ctDNA for Colorectal and Pancreatic Cancers Read More More Press Releases
Press Release - August 04, 2022 Personalis to Participate at the 7th Annual Needham Virtual Med Tech & Diagnostics 1x1 Conference Read More More Press Releases
Press Release - August 03, 2022 Personalis Reports Second Quarter 2022 Financial Results Read More More Press Releases
Press Release - August 02, 2022 Personalis Files Patent Infringement Lawsuit Against Foresight Diagnostics Read More More Press Releases
Press Release - July 20, 2022 Personalis to Announce Second Quarter 2022 Financial Results Read More More Press Releases
Press Release - July 12, 2022 Personalis Announces Expansion of Its Patent Portfolio Related to Tumor-Informed Detection of Molecular Residual Disease Read More More Press Releases
